HLN.LLSE
Haleon plc
£336.70
ListedJul 18, 2022
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryUnited Kingdom
Employees24535
State-| CityWeybridge| AddressThe Heights| Phone44 1932 959 500
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
18.7
?
Div. Rate
£0.07
?
Div. Yield
2.11%
?
Payout Ratio
36.76%
?
Max Consec. Div. Years
3 years
?
Longest Consec. Div.
3 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.24
?
Div. Growth Rate
100.00%
?
Score
93

Dividend History

Historical dividend payments by ex-dividend date.

Apr 9, 2026
£ 4.9000
Aug 14, 2025
£ 2.2000
Apr 24, 2025
£ 4.6000
Aug 15, 2024
£ 2.0000
Mar 14, 2024
£ 4.2000
Aug 24, 2023
£ 1.8000
Mar 16, 2023
£ 2.4000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!